A Nasdaq listed clinical-stage biopharmaceutical company focused on developing transformative genome-edited allogeneic cell therapies for devastating human diseases.
Caribou Biosciences is a pioneer at the cutting edge of genome editing and cell therapy development and was cofounded by 2020 Nobel Prize winner Jennifer Doudna.
please add this asap.
3 Likes
I would be grateful if this was added too
2 Likes